D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 92 Citations 32,887 502 World Ranking 6982 National Ranking 3769

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

Jonathan W. Said mainly focuses on Pathology, Cancer research, Lymphoma, Internal medicine and Immunology. His work in Pathology is not limited to one particular discipline; it also encompasses Cancer. His Cancer research research is multidisciplinary, relying on both Gene expression, Cancer cell, Apoptosis, Breast cancer and Prostate cancer.

His Lymphoma study integrates concerns from other disciplines, such as T cell, AIDS-related lymphoma and B cell. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology. Jonathan W. Said has researched Primary effusion lymphoma in several fields, including Kaposi's sarcoma-associated herpesvirus and Growth factor.

His most cited work include:

  • Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas (2445 citations)
  • Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. (794 citations)
  • Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression (589 citations)

What are the main themes of his work throughout his whole career to date?

Jonathan W. Said spends much of his time researching Pathology, Cancer research, Internal medicine, Lymphoma and Immunology. The study incorporates disciplines such as T cell, Immunophenotyping and Immunoperoxidase in addition to Pathology. His study focuses on the intersection of Cancer research and fields such as In vivo with connections in the field of Pharmacology.

His Internal medicine study incorporates themes from Endocrinology and Oncology. His research integrates issues of Virus, Virology and B cell in his study of Lymphoma. His work carried out in the field of Renal cell carcinoma brings together such families of science as Carcinoma, Surgery, Nephrectomy and Kidney disease.

He most often published in these fields:

  • Pathology (42.86%)
  • Cancer research (24.66%)
  • Internal medicine (24.27%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer research (24.66%)
  • Internal medicine (24.27%)
  • Immunology (15.26%)

In recent papers he was focusing on the following fields of study:

Jonathan W. Said focuses on Cancer research, Internal medicine, Immunology, Pathology and Oncology. His Cancer research research is multidisciplinary, incorporating perspectives in Cyclin D1, Gene silencing, Oncogene and Cell growth. His research on Internal medicine frequently links to adjacent areas such as Endocrinology.

His Immunology study frequently involves adjacent topics like Cancer. The various areas that Jonathan W. Said examines in his Pathology study include Large cell and PTEN. His Lymphoma research is multidisciplinary, incorporating perspectives in T cell and Gene rearrangement.

Between 2014 and 2021, his most popular works were:

  • Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. (78 citations)
  • HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads (77 citations)
  • HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads (77 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Cancer research, Immunology, Pathology, Lymphoma and Immune system are his primary areas of study. His Cancer research research is multidisciplinary, relying on both T cell, Transcription factor, Regulation of gene expression, Gene silencing and Bromodomain. As part of his studies on Pathology, Jonathan W. Said frequently links adjacent subjects like PTEN.

His study looks at the intersection of PTEN and topics like Cancer with Clear cell renal cell carcinoma. His Lymphoma research includes elements of Gene rearrangement and Germline mutation. His Immune system research incorporates themes from Acquired immunodeficiency syndrome, Viral load, Lymph node and Autopsy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas

Ethel Cesarman;Yuan Chang;Patrick S. Moore;Jonathan W. Said.
The New England Journal of Medicine (1995)

3207 Citations

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

E Elstner;C Müller;K Koshizuka;E A Williamson.
Proceedings of the National Academy of Sciences of the United States of America (1998)

1037 Citations

Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

Amnon Zisman;Allan J. Pantuck;Fredrick Dorey;Jonathan W. Said.
Journal of Clinical Oncology (2001)

892 Citations

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

Young E. Whang;Xinyi Wu;Hiroyoshi Suzuki;Robert E. Reiter.
Proceedings of the National Academy of Sciences of the United States of America (1998)

888 Citations

Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma

Amnon Zisman;Allan J. Pantuck;Jeffery Wieder;Debby H. Chao.
Journal of Clinical Oncology (2002)

811 Citations

Ligand for Peroxisome Proliferator-activated Receptor γ (Troglitazone) Has Potent Antitumor Effect against Human Prostate Cancer Both in Vitro and in Vivo

T Kubota;K Koshizuka;E A Williamson;H Asou.
Cancer Research (1998)

752 Citations

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

Gu Z;Thomas G;Yamashiro J;Shintaku Ip.
Oncogene (2000)

589 Citations

Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

David J. Andorsky;Reiko E. Yamada;Jonathan Said;Geraldine S. Pinkus.
Clinical Cancer Research (2011)

416 Citations

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow.
Blood (2014)

412 Citations

Evidence for Clonal Outgrowth of Androgen-independent Prostate Cancer Cells from Androgen-dependent Tumors through a Two-Step Process

Noah Craft;Chloe Chhor;Chris Tran;Arie Belldegrun.
Cancer Research (1999)

400 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jonathan W. Said

H. Phillip Koeffler

H. Phillip Koeffler

Cedars-Sinai Medical Center

Publications: 115

Arie S. Belldegrun

Arie S. Belldegrun

University of California, Los Angeles

Publications: 96

Allan J. Pantuck

Allan J. Pantuck

University of California, Los Angeles

Publications: 87

Bradley C. Leibovich

Bradley C. Leibovich

Mayo Clinic

Publications: 85

Annunziata Gloghini

Annunziata Gloghini

University of Milan

Publications: 79

Ethel Cesarman

Ethel Cesarman

Cornell University

Publications: 76

Antonino Carbone

Antonino Carbone

Centro di Riferimento Oncologico

Publications: 71

Blossom Damania

Blossom Damania

University of North Carolina at Chapel Hill

Publications: 71

Thomas F. Schulz

Thomas F. Schulz

Hannover Medical School

Publications: 68

Elaine S. Jaffe

Elaine S. Jaffe

National Institutes of Health

Publications: 67

John C. Cheville

John C. Cheville

Mayo Clinic

Publications: 67

Dirk P. Dittmer

Dirk P. Dittmer

University of North Carolina at Chapel Hill

Publications: 65

Christine M. Lohse

Christine M. Lohse

Mayo Clinic

Publications: 63

Jae U. Jung

Jae U. Jung

University of Southern California

Publications: 58

Patrick S. Moore

Patrick S. Moore

University of Pittsburgh

Publications: 55

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 54

Trending Scientists

Andrei Khrennikov

Andrei Khrennikov

Linnaeus University

Robert L. Grossman

Robert L. Grossman

University of Chicago

Michael Hochberg

Michael Hochberg

Luminous Computing

Guofu Niu

Guofu Niu

Auburn University

Michael Haumann

Michael Haumann

Freie Universität Berlin

Jin-Feng Jia

Jin-Feng Jia

Shanghai Jiao Tong University

Melvin Robert Jackson

Melvin Robert Jackson

General Electric (United States)

Susan Kalisz

Susan Kalisz

University of Tennessee at Knoxville

Eric Larose

Eric Larose

Grenoble Alpes University

Richard W. Murray

Richard W. Murray

Boston University

Frank Holland

Frank Holland

Forschungszentrum Jülich

Ronald E. McRoberts

Ronald E. McRoberts

University of Minnesota

Marco Sassoè-Pognetto

Marco Sassoè-Pognetto

University of Turin

Daniel N. Osherson

Daniel N. Osherson

Princeton University

Justin C.Y. Wu

Justin C.Y. Wu

Chinese University of Hong Kong

Something went wrong. Please try again later.